Compliance Question of the Week – Laboratory

Is there coverage for initial screening for hepatitis C virus (HCV) for adults at high risk for HCV infection?

Can we code diagnoses with terms documented such as “probable,” and “suspected?”

When testing is conducted on a single specimen source such as urine, do we need to report a modifier?

What is the Saving Access to Laboratory Service Act?

What types of tests will be impacted by lab reimbursement cuts if these cuts are finalized for next year?

Do we need a modifier for the submitting claims for screening of Medicare beneficiaries diagnosed with pre-diabetes?

For postmortem examination coding, how are the terms newborn, infant, and macerated stillborn defined?

Can we report 88380 in conjunction with 88381?

When billing for 88362 and 88380 on the same date of service what should we include in the documentation? Is a modifier necessary?

Do any new codes exist for reporting the transfusion of medicine-related GSP services?